 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/22/2023 |
$1.89 |
$1.89 |
$1.85 |
$1.87 |
12.50K | | 11/24/2023 |
$1.86 |
$1.95 |
$1.86 |
$1.95 |
23.50K | | 11/27/2023 |
$1.95 |
$1.95 |
$1.91 |
$1.94 |
12.40K | | 11/28/2023 |
$1.95 |
$1.95 |
$1.89 |
$1.90 |
6.00K | | 11/29/2023 |
$1.88 |
$1.94 |
$1.88 |
$1.90 |
28.40K |
|
|
| ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. | |
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on November 22, 2023, ABIO opened at $1.89, traded as high as $1.89 and as low as $1.85, and closed at $1.87. Trading volume was a total of 12.50K shares. On November 24, 2023, ABIO opened at $1.86, traded as high as $1.95 and as low as $1.86, and closed at $1.95. Trading volume was a total of 23.50K shares. On November 27, 2023, ABIO opened at $1.95, traded as high as $1.95 and as low as $1.91, and closed at $1.94. Trading volume was a total of 12.40K shares. On November 28, 2023, ABIO opened at $1.95, traded as high as $1.95 and as low as $1.89, and closed at $1.90. Trading volume was a total of 6.00K shares. On November 29, 2023, ABIO opened at $1.88, traded as high as $1.94 and as low as $1.88, and closed at $1.90. Trading volume was a total of 28.40K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/02/2013 |
|
| End date: |
11/29/2023 |
|
| Start price/share: |
$177.66 |
|
| End price/share: |
$1.90 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.93% |
|
| Average Annual Total Return: |
-36.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$106.90 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 11/22/2023 | $1.87 | | 11/24/2023 | $1.95 | | 11/27/2023 | $1.94 | | 11/28/2023 | $1.90 | | 11/29/2023 | $1.90 |
|
|
Free ABIO Email Alerts:
